DOH Alarmed After Manufacturer Admits Dengue Vaccine Poses Risks
Ringo | On 01, Dec 2017
The dengue vaccine, which can be a very big help in the Philippines and other nations, turned out can result negative to some.
The Department of Health (DOH) was alarmed after Sanofi Pasture, the creator of the dengue vaccine, admitted that though it provides protective benefits against people who have suffered from the disease, it may pose several risks to people who never had dengue.
“The analysis confirmed that Dengvaxia provides persistent protective benefit against dengue fever in those who had prior infection. For those not previously infected by dengue virus, however, the analysis found that in the longer term, more cases of severe disease could occur following vaccination upon a subsequent dengue infection,” the Sanofi said in a statement.
The DWIZ reported that the DOH was alarmed by the admission of Sanofi.DOH Secretary Francisco Duque ordered the Dengue Technical and Management Committee to formulate the next actions.
“The safety of the children vaccinated is paramount, and the Health Department will need to do surveillance of those given Dengvaxia with no prior infection. It’s really a big task,” said Duque.
The Philippines is the first country to approve the vaccine for individuals aged nine to 45-years-old. The DOH, along with the Department of Education (DepEd) vaccinated almost half a million children in the first phase. The third phase was just finished.